Literature DB >> 8062225

Two significant aspects of microcystin-LR: specific binding and liver specificity.

R Nishiwaki1, T Ohta, E Sueoka, M Suganuma, K Harada, M F Watanabe, H Fujiki.   

Abstract

Microcystin-LR is a unique and potent liver tumor promoter, belonging to the okadaic acid class compounds. Although microcystin-LR is a potent inhibitor of protein phosphatases 1 and 2A, as is okadaic acid, microcystin-LR has liver specificity dominance. Two significant aspects, specific binding and liver specificity of [3H]dihydromicrocystin-LR, a reduced form of microcystin-LR, were studied and compared with those of [3H]okadaic acid. [3H]-Dihydromicrocystin-LR had higher affinity for the receptors in both the particulate and cytosolic fractions of rat liver and various tissues than had [3H]okadaic acid. Intraperitoneal administration of [3H]dihydromicrocystin-LR into mice resulted in the highest uptake into the liver, 71.5 +/- 6.9% of the total administered radioactivity, whereas p.o. administration resulted in less than 1% uptake into the liver, suggesting that the mechanisms of the incorporation of microcystin-LR into the liver by i.p. and p.o. administrations are greatly different. The presence of associated forms of [3H]dihydromicrocystin-LR with macromolecules in the liver indicates a need for further investigation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8062225     DOI: 10.1016/0304-3835(94)90331-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

Review 1.  Toxic mechanisms of microcystins in mammals.

Authors:  Nicole L McLellan; Richard A Manderville
Journal:  Toxicol Res (Camb)       Date:  2017-04-24       Impact factor: 3.524

2.  Expression of the tumor necrosis factor alpha gene and early response genes by nodularin, a liver tumor promoter, in primary cultured rat hepatocytes.

Authors:  E Sueoka; N Sueoka; S Okabe; T Kozu; A Komori; T Ohta; M Suganuma; S J Kim; I K Lim; H Fujiki
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

3.  Treatment of cyanobacterial (microcystin) toxicosis using oral cholestyramine: case report of a dog from Montana.

Authors:  Kelly A Rankin; Karen A Alroy; Raphael M Kudela; Stori C Oates; Michael J Murray; Melissa A Miller
Journal:  Toxins (Basel)       Date:  2013-06       Impact factor: 4.546

4.  Assessing potential health risks from microcystin toxins in blue-green algae dietary supplements.

Authors:  D J Gilroy; K W Kauffman; R A Hall; X Huang; F S Chu
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

5.  The Comparative Toxicity of 10 Microcystin Congeners Administered Orally to Mice: Clinical Effects and Organ Toxicity.

Authors:  Neil Chernoff; Donna Hill; Johnsie Lang; Judy Schmid; Thao Le; Amy Farthing; Hwa Huang
Journal:  Toxins (Basel)       Date:  2020-06-18       Impact factor: 4.546

Review 6.  Microcystin Toxicokinetics, Molecular Toxicology, and Pathophysiology in Preclinical Rodent Models and Humans.

Authors:  Tarana Arman; John D Clarke
Journal:  Toxins (Basel)       Date:  2021-07-29       Impact factor: 4.546

7.  Critical Role of Endoplasmic Reticulum Stress in Cognitive Impairment Induced by Microcystin-LR.

Authors:  Fei Cai; Jue Liu; Cairong Li; Jianghua Wang
Journal:  Int J Mol Sci       Date:  2015-11-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.